Scilex Holding Announces That Many National Pharmacy Chains And Independent Pharmacies Have Begun Stocking GLOPERBA, The First Oral Liquid Medicine For Prophylaxis Of Gout Flares

Author: Benzinga Newsdesk | June 11, 2024 09:12am

• Scilex launched its third commercial product, GLOPERBA® on June 10, 2024.
• Scilex has officially shipped its recently approved, GLOPERBA® to many national drug/pharmacy chains, as well as independent pharmacies.
• GLOPERBA® will be the first oral liquid medicine for prophylaxis of gout flares available beginning this week with a WAC Price of $595/bottle.
• Scilex is also in the process of negotiating similar potential stocking arrangements with additional pharmacy chains in the U.S.
• Scilex remains committed to ensuring broad access, awareness and strong supply for broad distribution efforts across the U.S.
  • Gout is a painful arthritic disorder affecting an estimated 9.2 million people in the United States1. As gout cases increase every year, treatment requirements increase. The gout treatment market is projected to be $2.0 billion in the U.S. by 2028 with a well-defined area of unmet need.

Posted In: SCLX